Invention Publication
- Patent Title: DIPHENHYDRAMINE SYRUP FORMULATION OR SUSPENSION
-
Application No.: US17821138Application Date: 2022-08-19
-
Publication No.: US20230165963A1Publication Date: 2023-06-01
- Inventor: Max Spielberg , David Johnson
- Applicant: Genexa Inc.
- Applicant Address: US GA Atlanta
- Assignee: Genexa Inc.
- Current Assignee: Genexa Inc.
- Current Assignee Address: US GA Atlanta
- Main IPC: A61K47/46
- IPC: A61K47/46 ; A61K36/35 ; A61P11/14 ; A61K47/26 ; A61K35/644 ; A61K36/9068 ; A61K36/9066 ; A61K9/00 ; A61K36/88 ; A61K36/235 ; A61K47/12 ; A61K31/167 ; A61K36/736 ; A61K36/074
Abstract:
A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
Information query
